Hexamethylmelamine (HEX) and melphalan (L-PAM) as second-line therapy in ovarian carcinoma

M. A. Tempero, A. Kessinger, H. M. Lemon

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)C-450
JournalProceedings of the American Society of Clinical Oncology
VolumeVol. 1
StatePublished - 1982

ASJC Scopus subject areas

  • General Medicine

Cite this